1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 24492292 | The ErbB2-targeting antibody trastuzumab and the small-molecule SRC inhibitor saracatinib synergistically inhibit ErbB2-overexpressing gastric cancer. | 2014 Mar-Apr | 1 |